JP2025138644A5 - - Google Patents

Info

Publication number
JP2025138644A5
JP2025138644A5 JP2025089202A JP2025089202A JP2025138644A5 JP 2025138644 A5 JP2025138644 A5 JP 2025138644A5 JP 2025089202 A JP2025089202 A JP 2025089202A JP 2025089202 A JP2025089202 A JP 2025089202A JP 2025138644 A5 JP2025138644 A5 JP 2025138644A5
Authority
JP
Japan
Prior art keywords
nanoparticle
cationic lipid
nucleic acid
pharmaceutical composition
layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025089202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025138644A (ja
Filing date
Publication date
Priority claimed from JP2022503898A external-priority patent/JP7783628B2/ja
Application filed filed Critical
Publication of JP2025138644A publication Critical patent/JP2025138644A/ja
Publication of JP2025138644A5 publication Critical patent/JP2025138644A5/ja
Pending legal-status Critical Current

Links

JP2025089202A 2019-07-19 2025-05-28 多層rnaナノ粒子 Pending JP2025138644A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201962876440P 2019-07-19 2019-07-19
US62/876,440 2019-07-19
US201962877598P 2019-07-23 2019-07-23
US62/877,598 2019-07-23
US201962884983P 2019-08-09 2019-08-09
US62/884,983 2019-08-09
US201962933326P 2019-11-08 2019-11-08
US62/933,326 2019-11-08
JP2022503898A JP7783628B2 (ja) 2019-07-19 2020-07-17 多層rnaナノ粒子
PCT/US2020/042606 WO2021016106A1 (en) 2019-07-19 2020-07-17 Multilamellar rna nanoparticles

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022503898A Division JP7783628B2 (ja) 2019-07-19 2020-07-17 多層rnaナノ粒子

Publications (2)

Publication Number Publication Date
JP2025138644A JP2025138644A (ja) 2025-09-25
JP2025138644A5 true JP2025138644A5 (cg-RX-API-DMAC7.html) 2026-02-20

Family

ID=74193752

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022503898A Active JP7783628B2 (ja) 2019-07-19 2020-07-17 多層rnaナノ粒子
JP2025089202A Pending JP2025138644A (ja) 2019-07-19 2025-05-28 多層rnaナノ粒子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022503898A Active JP7783628B2 (ja) 2019-07-19 2020-07-17 多層rnaナノ粒子

Country Status (8)

Country Link
US (1) US20220287969A1 (cg-RX-API-DMAC7.html)
EP (1) EP3999034A4 (cg-RX-API-DMAC7.html)
JP (2) JP7783628B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220035434A (cg-RX-API-DMAC7.html)
AU (2) AU2020316335B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022000925A2 (cg-RX-API-DMAC7.html)
CA (1) CA3144388A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021016106A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3168509A1 (en) * 2020-02-19 2021-08-26 Elias SAYOUR Multilamellar rna nanoparticles and methods of sensitizing tumors to treatment with immune checkpoint inhibitors
AU2021247163A1 (en) * 2020-04-01 2022-10-20 University Of Florida Research Foundation, Incorporated Multilamellar RNA nanoparticle vaccine against SARS-CoV-2
US20240238418A1 (en) * 2021-05-07 2024-07-18 University Of Florida Research Foundation, Inc. Car t cell therapy method
WO2024263713A1 (en) * 2023-06-21 2024-12-26 University Of Florida Research Foundation, Incorporated Materials and methods of using proinsulin mrna nanoparticles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011112597A1 (en) * 2010-03-08 2011-09-15 Northeastern University Magnetic nanoplatforms for theranostic and multi-modal imaging applications
KR20220025112A (ko) * 2011-06-08 2022-03-03 샤이어 휴먼 지네틱 테라피즈 인크. Mrna 전달을 위한 지질 나노입자 조성물 및 방법
EA201492055A1 (ru) * 2012-06-08 2015-11-30 Шир Хьюман Дженетик Терапис, Инк. ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
ITRM20120480A1 (it) * 2012-10-09 2014-04-10 Uni Degli Studi Camerino Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione.
EP3049065A1 (en) 2013-09-26 2016-08-03 BioNTech AG Particles comprising a shell with rna
JP2017520549A (ja) 2014-06-26 2017-07-27 ラモット アット テル アビブ ユニバーシティ, リミテッド 核酸の送達のためのリポソーム製剤
WO2017062502A1 (en) * 2015-10-05 2017-04-13 The Regents Of The University Of Colorgo, A Body Corporate Lipoplexes formulated for catalytic delivery
US20210077399A1 (en) * 2018-05-08 2021-03-18 University Of Florida Research Foundation, Incorporated Magnetic liposomes and related treatment and imaging methods
WO2020037102A1 (en) * 2018-08-15 2020-02-20 University Of Florida Research Foundation, Inc. Methods of sensitizing tumors to treatment with immune checkpoint inhibitors
US20220054610A1 (en) * 2018-09-12 2022-02-24 University Of Florida Research Foundation, Inc. Slow-cycling cell-rna based nanoparticle vaccine to treat cancer
US20230096704A1 (en) * 2020-02-05 2023-03-30 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer
CA3168509A1 (en) * 2020-02-19 2021-08-26 Elias SAYOUR Multilamellar rna nanoparticles and methods of sensitizing tumors to treatment with immune checkpoint inhibitors
AU2021247163A1 (en) * 2020-04-01 2022-10-20 University Of Florida Research Foundation, Incorporated Multilamellar RNA nanoparticle vaccine against SARS-CoV-2
US20240299516A1 (en) * 2020-12-21 2024-09-12 University Of Florida Research Foundaton, Inc. Multilamellar rna nanoparticle vaccine against cancer
US20240238418A1 (en) * 2021-05-07 2024-07-18 University Of Florida Research Foundation, Inc. Car t cell therapy method
US20250231177A1 (en) * 2022-04-04 2025-07-17 University Of Florida Research Foundation, Inc. Method of characterizing tumors

Similar Documents

Publication Publication Date Title
Rommasi et al. Liposomal nanomedicine: applications for drug delivery in cancer therapy
Belhadj et al. Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles
JP2023520506A5 (cg-RX-API-DMAC7.html)
CN109152735B (zh) 包含亲脂性抗炎剂的脂质纳米颗粒及其使用方法
JP2023512707A5 (cg-RX-API-DMAC7.html)
EP2459724B1 (en) Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
Ai et al. Cartilage‐targeting ultrasmall lipid‐polymer hybrid nanoparticles for the prevention of cartilage degradation
Yuan et al. A novel self‐assembly albumin nanocarrier for reducing doxorubicin‐mediated cardiotoxicity
JP2019519568A5 (cg-RX-API-DMAC7.html)
CN112076158B (zh) 一种治疗慢性肾炎的脂质体-纳米粒复合体
Lu et al. Environment‐responsive lipid/siRNA nanoparticles for cancer therapy
JP2023515927A5 (cg-RX-API-DMAC7.html)
US20240141344A1 (en) Rna plasmid delivery system and application thereof
CN113384530B (zh) 一种多糖核心Nanocells及其制备方法与应用
JP2021523145A5 (cg-RX-API-DMAC7.html)
WO2022206734A1 (zh) 一种基因线路、rna递送系统及其应用
Shanker et al. Tumor suppressor gene‐based nanotherapy: from test tube to the clinic
Marcato Pharmacokinetics and pharmacodynamics of nanomaterials
CN119405823B (zh) 一种基于g四链体rna的蛋白降解靶向嵌合体及其制备方法与应用
CN103181897A (zh) 吉非替尼脂质体制剂及其制备方法
Xu et al. Conversion of chemical drugs into targeting ligands on RNA nanoparticles and assessing payload stoichiometry for optimal biodistribution in cancer treatment
Grandhi et al. Design, synthesis, and functionalization of nanomaterials for therapeutic drug delivery
CN113660938A (zh) 核酸递送复合物
CN117017942A (zh) 一种负载d-柠檬烯和miR195纳米给药系统及其制备方法、应用
CN101269223B (zh) 蒽环类药物纳米剂型及其制备方法和应用